Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New online tool aims to ease tough End-of-Life talks for cancer patients

NCT ID NCT06061965

First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 22 times

Summary

This study tested a website designed to help people with advanced cancer and their family caregivers talk about advance care planning. Researchers worked with 36 patient-caregiver pairs to see if the website was easy to use and helpful. The main goal was to gather feedback to improve the website, not to measure health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Illinois Chicago

    Chicago, Illinois, 60607, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Web-based resilience-building intervention

What this could lead to

If successful, this could lead to a practical online tool that makes it easier for cancer patients and their families to have important conversations about future medical care.

What could go wrong

This was a very small, early-stage usability study with only 36 participants. It focused on refining the website design, not on measuring health outcomes, so it's unclear if the tool actually improves care planning.

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.